BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34196992)

  • 1. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
    Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
    J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study.
    He T; Yu D; Wang Z; Guo C; Chang Y; Wang D
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients.
    Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P
    J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis.
    Cai Y; Wu D; Zhan L
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101796. PubMed ID: 34500119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma.
    Zhang T; Shi W; Tian K; Kong Y
    World J Surg Oncol; 2020 Jul; 18(1):156. PubMed ID: 32631353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCT6A dysregulation in surgical prostate cancer patients: association with disease features, treatment information, and prognosis.
    Peng S; Yu J; Wang Y
    Ir J Med Sci; 2024 Feb; 193(1):85-93. PubMed ID: 37523068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.
    Shen HW; Tan JF; Shang JH; Hou MZ; Liu J; He L; Yao SZ; He SY
    Arch Gynecol Obstet; 2016 Aug; 294(2):333-42. PubMed ID: 26695643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion.
    Wang N; Chen Y; Wu J
    Oncol Lett; 2023 May; 25(5):201. PubMed ID: 37113398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.
    Zhang W; Hou T; Niu C; Song L; Zhang Y
    PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCT6A, a novel prognostic biomarker for Ewing sarcoma.
    Jiang J; Liu C; Xu G; Liang T; Yu C; Liao S; Zhang Z; Lu Z; Wang Z; Chen J; Chen T; Li H; Zhan X
    Medicine (Baltimore); 2021 Jan; 100(4):e24484. PubMed ID: 33530265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer.
    Huang K; Zeng Y; Xie Y; Huang L; Wu Y
    Mol Med Rep; 2019 May; 19(5):4344-4352. PubMed ID: 30942452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of metastasis tumor-associated protein 2 in cervical squamous carcinoma and 
its relationship with prognosis].
    Xiao L; Huang S; Cheng H; Chen J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1031-1038. PubMed ID: 27807324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
    Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
    Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
    Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
    Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
    Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
    Ouyang F; Liu J; Xia M; Lin C; Wu X; Ye L; Song L; Li J; Wang J; Guo P; He M
    Oncol Rep; 2017 May; 37(5):2652-2662. PubMed ID: 28405687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.